Singapore's Chikungunya Cases Increase Over 30%

The Communicable Diseases Agency of the Republic of Singapore has reported a total of 21 chikungunya cases this year.

As of August 28, 2025, this number has already surpassed the total recorded for all of 2024, which was 15 cases.

The increase began in May 2025, primarily due to travelers returning from areas affected by the chikungunya outbreak in China's Guangdong Province and several French Territories in the western Indian Ocean.

In 2024, this sovereign island country and city-state in Southeast Asia welcomed approximately 16.5 million international tourists, representing a 20% increase from the previous year.

In early August, Professor Ooi Eng Eong from Duke-NUS Medical School explained to the media that although chikungunya is less deadly than dengue, it can be debilitating. Chronic joint discomfort can limit physical activity and impact overall quality of life.

Although the U.S. CDC has not issued a Travel Health Advisory for chikungunya related to Singapore, the UK's Travel Health Pro indicates that there is a risk of chikungunya in this country.

As of September 3, 2025, the UK recommends that international travelers take precautions to avoid mosquito bites, especially during daytime hours.

Additionally, vaccination may be considered for individuals aged 12 years and older who meet specific eligibility criteria.

In the United States, the FDA has approved a chikungunya vaccine, which is available at travel clinics and pharmacies.